[1]
D. Anand, D. A. Mittal, D. M. Kaushik, D. A. Pramod, Dr Javed, and D. R. Rath, “Cardiometabolic Effectiveness and Safety of SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus at High Cardiovascular Risk: A Prospective Observational Study”, Adolescência e Saúde, pp. 454–458, Sep. 2026.